About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

iSTAT Comparison Study, IRB3785 | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT02208895

iSTAT Comparison Study, IRB3785

Pleural fluid glucose levels measured with bed-side point of care methods such as finger stick glucometers and I-STAT device correlate with the traditional in-lab testing methods.

Lead sponsor: University of Oklahoma•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University of Oklahoma

This is a prospective study which will identify patients in VAMC with a diagnosis of pleural effusion and undergoing diagnostic thoracentesis.The investigators plan to analyze the two bedside point-of-care fluid glucose testing methods (I- STAT device and finger stick glucometer) to measure pleural fluid glucose levels. The results obtained from these two methods will be compared to the traditionally in lab measured pleural fluid glucose levels.

Age

18 - 99 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•any patient 18 to 99 year old with a diagnosis of pleural effusion and undergoing a diagnostic thoracentesis.

Exclusion Criteria

•Inability to provide informed consent by the patient or the surrogate to enroll for the planned study.

Related studies

Impact of Pleural Manometry on the Assessment and Treatment of Malignant Pleural Effusion: A Pilot Clinical Trial

NCT07120867 · Malignant Pleural Effusions (Mpe)

RECRUITINGPhase 2

Evaluating the Efficacy and Safety of Saline Irrigation as an Add-On Therapy for Retained Pleural Infections [LYTICS +]

NCT06713382 · Pleural Effusion Associated With Pulmonary Infection, Pleural Effusion Disorder, and more

Enrolling By Invitation

Biomarker Levels During Indwelling Pleural cAtheter Sample Testing

NCT02092155 · Malignant Pleural Effusions

Not Yet RecruitingNA

Xuan Yin Ning Plus Bevacizumab for Malignant Pleural Effusion

NCT07670338 · Malignant Pleural Effusions (Mpe)

Not Yet RecruitingPhase 2

A Phase II Study to Evaluate JMKX000197 Injection Versus Cisplatin in the Treatment of Malignant Pleural Effusion

NCT07649369 · Malignant Pleural Effusions (Mpe)

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 6, 2020Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment60

Start dateFeb 2014

Last updatedMar 6, 2020

Condition

Pleural Effusions

Locations shown

VAMC OKC

Oklahoma City, Oklahoma

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 6, 2020Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions